Amazing news: "Through the grant of QIDP designation, RECCE® 327 is labeled for Fast Track designation which is designed to speed the FDA’s review process and allows QIDP designated drugs that treat serious or life-threatening conditions and fill an unmet medical need, to be expedited for review in order to facilitate their development."
Ann: US FDA Grants Qualified Infectious Disease Product Designati, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
-0.050(11.9%) |
Mkt cap ! $106.9M | |||
| Open | High | Low | Value | Volume |
| 40.0¢ | 42.0¢ | 37.0¢ | $74K | 183.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 28000 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 1911 | 2 |
View Market Depth
| Last trade - 15.45pm 29/07/2025 (20 minute delay) ? |
| RCE (ASX) Chart |